Home » Pharma & Healthcare » Global RNAi for Therapeutic Market by Player, Region, Type, Application and Sales Channel, Forecast 2021-2030

Global RNAi for Therapeutic Market by Player, Region, Type, Application and Sales Channel, Forecast 2021-2030

  118 Pages     Pharma & Healthcare  

Available Formats      

Report ID: 82541
Published By: MAResearch

Summary

The Global RNAi for Therapeutic Market was valued at $XX million in 2020, and research analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030.

This report studies the RNAi for Therapeutic market, covering market size for segment by type (siRNA, miRNA, etc.), by application (Cancer, Cardiovascular, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for RNAi for Therapeutic from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the RNAi for Therapeutic market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of RNAi for Therapeutic including:

  • Alnylam Pharmaceuticals
  • Arbutus Biopharma (Tekmira)
  • Arrowhead
  • Dicerna Pharmaceuticals
  • Mirna Therapeutics
  • Quark Pharmaceuticals
  • RXi Pharmaceuticals
  • Silence Therapeutics
  • Benitec Biopharma
  • miRagen Therapeutics
  • Sylentis
  • Gradalis
  • Sirnaomics
  • Silenseed

Market split by Type, can be divided into:

  • siRNA
  • miRNA
  • shRNA

Market split by Application, can be divided into:

  • Cancer
  • Cardiovascular
  • HBV
  • Other

Market split by Sales Channel, can be divided into:

  • Direct Channel
  • Distribution Channel

Market segment by Region/Country including:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

Chapter 1 RNAi for Therapeutic Market Overview

1.1 RNAi for Therapeutic Definition

1.2 Global RNAi for Therapeutic Market Size Status and Outlook (2015-2030)

1.3 Global RNAi for Therapeutic Market Size Comparison by Region (2015-2030)

1.4 Global RNAi for Therapeutic Market Size Comparison by Type (2015-2030)

1.5 Global RNAi for Therapeutic Market Size Comparison by Application (2015-2030)

1.6 Global RNAi for Therapeutic Market Size Comparison by Sales Channel (2015-2030)

1.7 RNAi for Therapeutic Market Dynamics (COVID-19 Impacts)

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Mergers/Acquisitions/Expansion)

1.7.4 COVID-19 Impacts on Current Market

1.7.5 Post-Strategies of COVID-19 Outbreak

Chapter 2 RNAi for Therapeutic Market Segment Analysis by Player

2.1 Global RNAi for Therapeutic Sales and Market Share by Player (2018-2020)

2.2 Global RNAi for Therapeutic Revenue and Market Share by Player (2018-2020)

2.3 Global RNAi for Therapeutic Average Price by Player (2018-2020)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Segment by Player

Chapter 3 RNAi for Therapeutic Market Segment Analysis by Type

3.1 Global RNAi for Therapeutic Market by Type

3.1.1 siRNA

3.1.2 miRNA

3.1.3 shRNA

3.2 Global RNAi for Therapeutic Sales and Market Share by Type (2015-2020)

3.3 Global RNAi for Therapeutic Revenue and Market Share by Type (2015-2020)

3.4 Global RNAi for Therapeutic Average Price by Type (2015-2020)

3.5 Leading Players of RNAi for Therapeutic by Type in 2020

3.6 Conclusion of Segment by Type

Chapter 4 RNAi for Therapeutic Market Segment Analysis by Application

4.1 Global RNAi for Therapeutic Market by Application

4.1.1 Cancer

4.1.2 Cardiovascular

4.1.3 HBV

4.1.4 Other

4.2 Global RNAi for Therapeutic Revenue and Market Share by Application (2015-2020)

4.3 Leading Consumers of RNAi for Therapeutic by Application in 2020

4.4 Conclusion of Segment by Application

Chapter 5 RNAi for Therapeutic Market Segment Analysis by Sales Channel

5.1 Global RNAi for Therapeutic Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global RNAi for Therapeutic Revenue and Market Share by Sales Channel (2015-2020)

5.3 Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2020

5.4 Conclusion of Segment by Sales Channel

Chapter 6 RNAi for Therapeutic Market Segment Analysis by Region

6.1 Global RNAi for Therapeutic Market Size and CAGR by Region (2015-2030)

6.2 Global RNAi for Therapeutic Sales and Market Share by Region (2015-2020)

6.3 Global RNAi for Therapeutic Revenue and Market Share by Region (2015-2020)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America RNAi for Therapeutic Market Share by Type

6.4.3 North America RNAi for Therapeutic Market Share by Application

6.4.4 United States

6.4.5 Canada

6.4.6 Mexico

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe RNAi for Therapeutic Market Share by Type

6.5.3 Europe RNAi for Therapeutic Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Russia

6.5.9 Spain

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific RNAi for Therapeutic Market Share by Type

6.6.3 Asia-Pacific RNAi for Therapeutic Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America RNAi for Therapeutic Market Share by Type

6.7.3 South America RNAi for Therapeutic Market Share by Application

6.7.4 Brazil

6.7.5 Argentina

6.7.6 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa RNAi for Therapeutic Market Share by Type

6.8.3 Middle East & Africa RNAi for Therapeutic Market Share by Application

6.8.4 UAE

6.8.5 Saudi Arabia

6.8.6 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading RNAi for Therapeutic Players

7.1 Alnylam Pharmaceuticals

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.1.4 COVID-19 Impact on Alnylam Pharmaceuticals

7.2 Arbutus Biopharma (Tekmira)

7.3 Arrowhead

7.4 Dicerna Pharmaceuticals

7.5 Mirna Therapeutics

7.6 Quark Pharmaceuticals

7.7 RXi Pharmaceuticals

7.8 Silence Therapeutics

7.9 Benitec Biopharma

7.10 miRagen Therapeutics

7.11 Sylentis

7.12 Gradalis

7.13 Sirnaomics

7.14 Silenseed

Chapter 8 Upstream and Downstream Analysis of RNAi for Therapeutic

8.1 Industrial Chain of RNAi for Therapeutic

8.2 Upstream of RNAi for Therapeutic

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.2.4 Manufacturing Cost Structure

8.2.5 Manufacturing Process

8.3 Downstream of RNAi for Therapeutic

8.3.1 Leading Distributors/Dealers of RNAi for Therapeutic

8.3.2 Leading Consumers of RNAi for Therapeutic

Chapter 9 Development Trend of RNAi for Therapeutic (2021-2030)

9.1 Global RNAi for Therapeutic Market Size (Sales and Revenue) Forecast (2021-2030)

9.2 Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2021-2030)

9.3 Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2021-2030)

9.4 Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2021-2030)

9.5 Global RNAi for Therapeutic Market Size and CAGR Forecast by Sales Channel (2021-2030)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

Figure RNAi for Therapeutic Example

Figure Global RNAi for Therapeutic Revenue (Million $) Status and Outlook (2015-2030)

Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Region (2015-2030)

Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Type (2015-2030)

Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Application (2015-2030)

Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Sales Channel (2015-2030)

Table Global RNAi for Therapeutic Sales by Player (2018-2020)

Table Global RNAi for Therapeutic Sales Market Share by Player (2018-2020)

Figure Global RNAi for Therapeutic Sales Market Share by Player in 2020

Table Global RNAi for Therapeutic Revenue (Million $) by Player (2018-2020)

Table Global RNAi for Therapeutic Revenue Market Share by Player (2018-2020)

Figure Global RNAi for Therapeutic Revenue Market Share by Player in 2020

Table Global RNAi for Therapeutic Average Price by Player (2018-2020)

Figure Global RNAi for Therapeutic Average Price by Player in 2020

Figure Global RNAi for Therapeutic Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018

Figure Global RNAi for Therapeutic Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020

Figure Example of siRNA

Figure Global siRNA Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of miRNA

Figure Global miRNA Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of shRNA

Figure Global shRNA Revenue (Million $) and Growth Rate (2015-2020)

Table Global RNAi for Therapeutic Sales by Type (2015-2020)

Table Global RNAi for Therapeutic Sales Market Share by Type (2015-2020)

Figure Global RNAi for Therapeutic Sales Market Share by Type in 2020

Table Global RNAi for Therapeutic Revenue (Million $) by Type (2015-2020)

Table Global RNAi for Therapeutic Revenue Market Share by Type (2015-2020)

Figure Global RNAi for Therapeutic Revenue Market Share by Type in 2020

Table Global RNAi for Therapeutic Average Price by Type (2015-2020)

Figure Global RNAi for Therapeutic Average Price by Type in 2020

Table Leading Players of RNAi for Therapeutic by Type in 2020

Figure Example of Cancer

Figure Global RNAi for Therapeutic for Cancer Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Cardiovascular

Figure Global RNAi for Therapeutic for Cardiovascular Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of HBV

Figure Global RNAi for Therapeutic for HBV Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Other

Figure Global RNAi for Therapeutic for Other Revenue (Million $) and Growth Rate (2015-2020)

Table Global RNAi for Therapeutic Sales by Application (2015-2020)

Table Global RNAi for Therapeutic Sales Market Share by Application (2015-2020)

Figure Global RNAi for Therapeutic Sales Market Share by Application in 2020

Table Leading Consumers of RNAi for Therapeutic by Application in 2020

Figure Example of Direct Channel

Figure Global RNAi for Therapeutic for Direct Channel Revenue (Million $) and Growth Rate (2015-2020)

Figure Example of Distribution Channel

Figure Global RNAi for Therapeutic for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020)

Table Global RNAi for Therapeutic Revenue by Sales Channel (2015-2020)

Table Global RNAi for Therapeutic Revenue Market Share by Sales Channel (2015-2020)

Figure Global RNAi for Therapeutic Revenue Market Share by Sales Channel in 2020

Table Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2020

Table Global RNAi for Therapeutic Market Size and CAGR by Region (2015-2030)

Table Global RNAi for Therapeutic Sales by Region (2015-2020)

Table Global RNAi for Therapeutic Sales Market Share by Region (2015-2020)

Figure Global RNAi for Therapeutic Sales Market Share by Region in 2020

Table Global RNAi for Therapeutic Revenue (Million $) by Region (2015-2020)

Table Global RNAi for Therapeutic Revenue Market Share by Region (2015-2020)

Figure Global RNAi for Therapeutic Revenue Market Share by Region in 2020

Table North America RNAi for Therapeutic Sales by Country (2015-2020)

Figure North America RNAi for Therapeutic Sales Market Share by Country (2015-2020)

Table North America RNAi for Therapeutic Revenue by Country (2015-2020)

Figure North America RNAi for Therapeutic Revenue Market Share by Country (2015-2020)

Figure North America RNAi for Therapeutic Market Share by Type in 2020

Figure North America RNAi for Therapeutic Market Share by Application in 2020

Figure United States RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure United States RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Canada RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Canada RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Mexico RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Mexico RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Table Europe RNAi for Therapeutic Sales by Country (2015-2020)

Figure Europe RNAi for Therapeutic Sales Market Share by Country (2015-2020)

Table Europe RNAi for Therapeutic Revenue by Country (2015-2020)

Figure Europe RNAi for Therapeutic Revenue Market Share by Country (2015-2020)

Figure Europe RNAi for Therapeutic Market Share by Type in 2020

Figure Europe RNAi for Therapeutic Market Share by Application in 2020

Figure Germany RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Germany RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure UK RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure UK RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure France RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure France RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Italy RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Italy RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Russia RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Russia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Spain RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Spain RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Table Asia-Pacific RNAi for Therapeutic Sales by Country (2015-2020)

Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Country (2015-2020)

Table Asia-Pacific RNAi for Therapeutic Revenue by Country (2015-2020)

Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Country (2015-2020)

Figure Asia-Pacific RNAi for Therapeutic Market Share by Type in 2020

Figure Asia-Pacific RNAi for Therapeutic Market Share by Application in 2020

Figure China RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure China RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Japan RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Japan RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Korea RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Korea RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure India RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure India RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Southeast Asia RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Southeast Asia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Australia RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Australia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Table South America RNAi for Therapeutic Sales by Country (2015-2020)

Figure South America RNAi for Therapeutic Sales Market Share by Country (2015-2020)

Table South America RNAi for Therapeutic Revenue by Country (2015-2020)

Figure South America RNAi for Therapeutic Revenue Market Share by Country (2015-2020)

Figure South America RNAi for Therapeutic Market Share by Type in 2020

Figure South America RNAi for Therapeutic Market Share by Application in 2020

Figure Brazil RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Brazil RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Argentina RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Argentina RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Colombia RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Colombia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Table Middle East & Africa RNAi for Therapeutic Sales by Country (2015-2020)

Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Country (2015-2020)

Table Middle East & Africa RNAi for Therapeutic Revenue by Country (2015-2020)

Figure Middle East & Africa RNAi for Therapeutic Revenue Market Share by Country (2015-2020)

Figure Middle East & Africa RNAi for Therapeutic Market Share by Type in 2020

Figure Middle East & Africa RNAi for Therapeutic Market Share by Application in 2020

Figure UAE RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure UAE RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure Saudi Arabia RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure Saudi Arabia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Figure South Africa RNAi for Therapeutic Sales and Growth Rate (2015-2020)

Figure South Africa RNAi for Therapeutic Revenue (Million $) and Growth Rate (2015-2020)

Table Company Snapshot of Alnylam Pharmaceuticals

Table RNAi for Therapeutic Introduction of Alnylam Pharmaceuticals

Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share of Alnylam Pharmaceuticals (2018-2020)

Table Industrial Chain of RNAi for Therapeutic

Table Manufacturing Cost Structure of RNAi for Therapeutic

Table General Manufacturing Process of RNAi for Therapeutic

Table Leading Distributors/Dealers of RNAi for Therapeutic

Table Leading Consumers of RNAi for Therapeutic

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast (2021-2030)

Figure Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2021-2030)

Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2021-2030)

Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2021-2030)

Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2021-2030)

Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Sales Channel (2021-2030)

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Futuremarkets.co | Powered By Upward Media Research, LLP | © 2021